QCM
BIOA

Quantinno Capital Management’s BioAge Labs BIOA Stock Holding History

Quantinno Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
51,188
+28,101
+122% +$508K ﹤0.01% 2387
2026
Q1 		$404K Buy
+23,087
New +$445K ﹤0.01% 2859

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Quantinno Capital Management's BIOA Position: Q2 2026 in Review

Quantinno Capital Management increased its BioAge Labs (BIOA) stake by 122% in Q2 2026, buying an estimated $508K and bringing the position to 51,188 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

Quantinno Capital Management first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Quantinno Capital Management held 51,188 shares of BioAge Labs worth $1.25M as of Q2 2026.
  • Quantinno Capital Management bought 28,101 BioAge Labs shares in Q2 2026, an estimated $508K.
  • BioAge Labs made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2387 holding.
  • Quantinno Capital Management first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.